Eleven Therapeutics

Recent Finacing

Seed

Recent Raise

$22M

Eleven Therapeutics develops programmable SCSI-RNA™ siRNA therapeutics using high-throughput combinatorial chemistry, AI to improve delivery and durability, targeting respiratory diseases with hubs in Cambridge, Boston, and Tel Aviv.

Founded 2020

Tel Aviv, Israel

11-50

Private

eleventx.com

Highlights

Focus Areas

Biotechnology

Medical

Product Research

Therapeutics

Recent Investors

Financials

$22M

Total Raised

1

Funding round

6

Investors

Team

Upgrade to view the team

See the team members at Eleven Therapeutics.